
Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market Report 2026
Global Outlook – By Type Of Equipment (Cell Culture Equipment, Bioreactors, Filtration Systems, Centrifuges, Incubators), By Technology (Automated Dulbecco’s Modified Eagle Medium (DMEM) Medium Preparation, Manual Dulbecco’s Modified Eagle Medium (DMEM) Medium Preparation, Hybrid Dulbecco’s Modified Eagle Medium (DMEM) Medium Preparation), By Distribution Channel (Direct Sales, Online Sales, Distributors And Resellers), By Application (Cell Culture, Tissue Engineering, Drug Development, Other Applications), By End-User (Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Academic Institutions, Contract Research Organizations (CROs)) – Market Size, Trends, Strategies, and Forecast to 2035
Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market Overview
• Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment market size has reached to $1.36 billion in 2025 • Expected to grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Rising Demand For Biological Drugs Driving The Growth Of The Market Due To Increasing Biologics Production Needs • Market Trend: Advancements In Automation And Food-Grade DMEM Media For Scalable Cell Culture Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market?
Dulbecco’s modified eagle medium (DMEM) medium equipment refers to specialized laboratory systems used for the preparation and maintenance of dulbecco’s modified eagle medium (DMEM), a nutrient-rich formulation essential for sustaining mammalian cell cultures. This equipment ensures that the medium retains its required physicochemical balance, supporting consistent cell growth, metabolism, and experimental accuracy in research and biomanufacturing applications. The main types of dulbecco’s modified eagle medium (DMEM) medium equipment are cell culture equipment, bioreactors, filtration systems, centrifuges, and incubators. Cell culture equipment refers to the specialized tools and devices used to grow and maintain cells under controlled laboratory conditions. It integrates various technologies, such as automated dulbecco’s modified eagle medium (DMEM) preparation, manual dulbecco’s modified eagle medium (DMEM) preparation, and hybrid dulbecco’s modified eagle medium (DMEM) preparation, and is distributed through direct sales, online sales, distributors, and resellers. It finds applications in cell culture, tissue engineering, drug development, and others, serving end-users, such as biotechnology companies, pharmaceutical companies, research institutions, academic institutions, and contract research organizations (CROs).
What Is The Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market Size and Share 2026?
The dulbecco’s modified eagle medium (dmem) medium equipment market size has grown strongly in recent years. It will grow from $1.36 billion in 2025 to $1.48 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to expansion of mammalian cell culture research, growth of biopharmaceutical manufacturing, increasing academic life science research, rising use of standardized culture media, availability of advanced laboratory infrastructure.What Is The Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market Growth Forecast?
The dulbecco’s modified eagle medium (dmem) medium equipment market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing investments in cell-based therapies, rising demand for automated laboratory workflows, expansion of regenerative medicine research, growing focus on reproducibility in experiments, increasing adoption of smart lab technologies. Major trends in the forecast period include increasing adoption of automated dmem preparation systems, rising demand for high-precision cell culture equipment, growing integration of hybrid medium preparation technologies, expansion of scalable bioreactor-based systems, enhanced focus on sterility and process consistency.Global Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market Segmentation
1) By Type Of Equipment: Cell Culture Equipment, Bioreactors, Filtration Systems, Centrifuges, Incubators 2) By Technology: Automated Dulbecco’s Modified Eagle Medium (DMEM) Medium Preparation, Manual Dulbecco’s Modified Eagle Medium (DMEM) Medium Preparation, Hybrid Dulbecco’s Modified Eagle Medium (DMEM) Medium Preparation 3) By Distribution Channel: Direct Sales, Online Sales, Distributors And Resellers 4) By Application: Cell Culture, Tissue Engineering, Drug Development, Other Applications 5) By End-User: Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Academic Institutions, Contract Research Organizations (CROs) Subsegments: 1) By Cell Culture Equipment: Laminar Flow Cabinets, Biosafety Cabinets, Cell Counters, Culture Vessels, Microscopes 2) By Bioreactors: Stirred Tank Bioreactors, Fixed Bed Bioreactors, Wave Bioreactors, Airlift Bioreactors, Perfusion Bioreactors 3) By Filtration Systems: Microfiltration Units, Ultrafiltration Units, Nanofiltration Units, Depth Filtration Units, Tangential Flow Filtration Systems 4) By Centrifuges: Benchtop Centrifuges, Floor Standing Centrifuges, Ultracentrifuges, Refrigerated Centrifuges, Microcentrifuges 5) By Incubators: Carbon Dioxide Incubators, Refrigerated Incubators, Humidity Controlled Incubators, Shaking Incubators, Stackable IncubatorsWhat Are The Drivers Of The Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market?
The rising demands of biological drugs are expected to propel the growth of the dulbecco’s modified eagle medium (DMEM) medium equipment market going forward. Biological drugs are medications made from living organisms or their components, such as proteins or antibodies, used to treat diseases like cancer, autoimmune disorders, and genetic conditions. Demand for biologics is increasing as health systems and manufacturers expand production to treat chronic, oncologic, and rare-disease indications. Dulbecco’s modified eagle medium (DMEM) medium equipment supports biological drugs by enabling reproducible medium preparation, tight physicochemical control, and scalable handling that manufacturers and labs need for consistent cell-based biologic production. For instance, in February 2025, according to the World Health Organization, a Switzerland-based health authority, as of 2023, the WHO Essential Medicines List included 81 biologic therapies, representing over 15% of all listed essential medicines. Therefore, the rising demands of biological drugs are driving the growth of the dulbecco’s modified eagle medium (DMEM) medium equipment industry. The rising investments in biopharmaceuticals are expected to propel the growth of the dulbecco’s modified eagle medium (DMEM) medium equipment market going forward. Investment in biopharmaceuticals refers to the allocation of financial resources into the research, development, and commercialization of pharmaceutical products. Investments in the biopharmaceutical sector are rising due to the increasing global demand for innovative therapies aimed at treating complex and chronic diseases, including cancer, autoimmune disorders, and rare genetic conditions. Investments in biopharmaceuticals benefit dulbecco’s modified eagle medium (DMEM) medium equipment by supporting the adoption of advanced cell culture systems, facilitating the acquisition of automated equipment, and enabling the scaling of research and production processes. For instance, in January 2025, according to the BioIndustry Association (BIA), a UK-based non-profit organization, in 2024, the UK biotech sector experienced substantial growth, securing $4.3 billion USD (£3.5 billion) in investment, representing a remarkable 94% increase from the previous year. Therefore, the rising investments in biopharmaceuticals are driving the growth of the dulbecco’s modified eagle medium (DMEM) medium equipment industry.Key Players In The Global Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market
Major companies operating in the dulbecco’s modified eagle medium (dmem) medium equipment market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Irvine Scientific Inc., GE Healthcare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Avantor Inc., Agilent Technologies Inc., Sartorius AG, Bio-Techne Corporation, MP Biomedicals LLC, HiMedia Laboratories Pvt. Ltd., Creative Bioarray Inc., Capricorn Scientific GmbH, US Biological Life Sciences Inc., PhytoTech Labs Inc., Alkali Scientific LLC, Genexis Biotech Pvt. Ltd., STEMCELL Technologies Inc., Bioartha Labs Private Limited.Global Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market Trends and Insights
Major companies operating in the dulbecco’s modified eagle medium (DMEM) medium equipment market are focusing on automation and miniaturization, such as automated cell culture systems, to enhance operational efficiency, reduce manual intervention, and improve reproducibility of experimental results. Automated cell culture systems refer to laboratory platforms that use robotics and sensors to perform cell culture processes with minimal human intervention, ensuring precise control, reproducibility, and scalability for research and biopharmaceutical applications. For instance, in May 2025, Multus Biotechnology Ltd., a UK-based biotechnology company, launched a new food-grade basal media called DMEM/F12-FG, specifically designed for cultivated meat production. This product is formulated to support cell growth by providing essential nutrients like sugars, salts, minerals, and vitamins, all compliant with food-grade standards. Developed through collaboration with global food and feed ingredient companies and utilizing AI for optimal formulation, it aims to facilitate scalable and regulatory-compliant cultivated meat manufacturing. The media is available in 500 ml and 1-liter bottles from their certified manufacturing facilities, enabling companies and researchers to test and accelerate their development processes aimed at commercial production.Regional Insights
North America was the largest region in the dulbecco’s modified eagle medium (DMEM) medium equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dulbecco’s modified eagle medium (dmem) medium equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dulbecco’s modified eagle medium (dmem) medium equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market?
The dulbecco’s modified eagle medium (DMEM) medium equipment market consists of sales of water bath systems, micropipette controllers, CO₂ monitors, shakers and mixers, and sterile workstations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market Report 2026?
The dulbecco’s modified eagle medium (dmem) medium equipment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dulbecco’s modified eagle medium (dmem) medium equipment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Dulbecco’s Modified Eagle Medium (DMEM) Medium Equipment Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.48 billion |
| Revenue Forecast In 2035 | $2.02 billion |
| Growth Rate | CAGR of 8.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type Of Equipment, Technology, Distribution Channel, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Irvine Scientific Inc., GE Healthcare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Avantor Inc., Agilent Technologies Inc., Sartorius AG, Bio-Techne Corporation, MP Biomedicals LLC, HiMedia Laboratories Pvt. Ltd., Creative Bioarray Inc., Capricorn Scientific GmbH, US Biological Life Sciences Inc., PhytoTech Labs Inc., Alkali Scientific LLC, Genexis Biotech Pvt. Ltd., STEMCELL Technologies Inc., Bioartha Labs Private Limited. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
